An evaluation of the AccuCinch Ventricular Restoration System in symptomatic heart failure patients with reduced ejection fraction (HFrEF) - Case Study
Aug. 23, 2022
Courtesy ofAncora Heart, Inc
Study Overview: Design: Prospective, randomized, open-label, multi-center, international, clinical safety and efficacy investigation. Randomization: Treatment with AccuCinch System plus guideline-directed medical therapy (GDMT) or GDMT alone. Enrollment: 400 randomized subjects at up to 80 centers worldwide
Most popular related searches
Stay in the loop!
Select your areas of interest to receive industry updates.